Studies presented at AMP Global conference in Berlin reaffirm powerful analytical performance and ease of use for the world’s first complete Sample to Insight NGS solution Hilden, Germany, April 3, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced further validation of the GeneReader NGS System with the publication of five new… Read article →
The inaugural AMP Global Congress on Molecular Pathology, hosted by the Association for Medical Pathologists (AMP), is the event of the year for molecular pathology, diagnostic technologies and research and clinical applications. AMP Global 2017 is the perfect event for QIAGEN to remind and educate the market about our broad menu of Sample to Insight… Read article →
Impressions from the QIAGEN booth at #ASHG2018 in San Diego. See you in Houston, TX in 2019! https://t.co/j3CQXsGK6E, Jennifer Poitras presents her poster at #ASHG2018 in San Diego on concordance of BRCA1/2 variant classification in… https://t.co/9nNN5M6I9q, Capture all relevant inherited mutations, including CNVs, SNVs, InDels and Fusions, for a range of rare hereditary… https://t.co/jqEeDtAhzP, Dr. Wenbo Xu, Lab Director at True Health Diagnostics, on the challenges faced in next generation sequencing when d… https://t.co/Zil7hj6cXy, Interested in gaining next-generation insights for hereditary disease? Visit the QIAGEN booth #1339 at #ASHG to lea… https://t.co/zhyXkZ7kDP, 
